Cargando…

Adjunctive fecal microbiota transplantation in supportive oncology: Emerging indications and considerations in immunocompromised patients

FMT has gained enormous momentum in the treatment of acute inflammatory and infectious diseases. Despite an encouraging safety profile, FMT has been met with caution in the oncological setting due to perceived infectious risks in immunocompromised patients. Theoretical risks aside, the application o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wardill, H.R., Secombe, K.R., Bryant, R.V., Hazenberg, M.D., Costello, S.P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603490/ https://www.ncbi.nlm.nih.gov/pubmed/30940601 http://dx.doi.org/10.1016/j.ebiom.2019.03.070

Ejemplares similares

Gut Microbiota-Derived Short-Chain Fatty Acids: Impact on Cancer Treatment Response and Toxicities
por: Al-Qadami, Ghanyah H., et al.
Publicado: (2022)

Investigating causality with fecal microbiota transplantation in rodents: applications, recommendations and pitfalls
por: Gheorghe, Cassandra E., et al.
Publicado: (2021)

Fecal Microbiota Transplantation (FMT) as an Adjunctive Therapy for Depression—Case Report
por: Doll, Jessica P. K., et al.
Publicado: (2022)

Fecal microbiota transplantation for refractory diarrhea in immunocompromised diseases: a pediatric case report
por: Zhong, Shuwen, et al.
Publicado: (2019)

Faecal microbiota transplantation: indications, evidence and safety
por: Soo, Wei Ting, et al.
Publicado: (2020)

Fecal Microbiota Transplantation Inhibits Multidrug-Resistant Gut Pathogens: Preliminary Report Performed in an Immunocompromised Host
por: Biliński, Jarosław, et al.
Publicado: (2016)

A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients
por: Shogbesan, Oluwaseun, et al.
Publicado: (2018)

Multidrug-Resistant Gram-Negative Bacteria Decolonization in Immunocompromised Patients: A Focus on Fecal Microbiota Transplantation
por: Alagna, Laura, et al.
Publicado: (2020)

Fecal Microbiota Transplant for Hematologic and Oncologic Diseases: Principle and Practice
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Guidelines for reporting on animal fecal transplantation (GRAFT) studies: recommendations from a systematic review of murine transplantation protocols
por: Secombe, Kate R., et al.
Publicado: (2021)

Comparison of the fecal bacterial microbiota of healthy and diarrheic foals at two and four weeks of life
por: Schoster, A., et al.
Publicado: (2017)

Recurrent Relatively Resistant Salmonella infantis Infection in 2 Immunocompromised Hosts Cleared With Prolonged Antibiotics and Fecal Microbiota Transplantation
por: Torres Soto, Mariam, et al.
Publicado: (2018)

Long-term taxonomic and functional divergence from donor bacterial strains following fecal microbiota transplantation in immunocompromised patients
por: Moss, Eli L., et al.
Publicado: (2017)

Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions
por: Borody, Thomas J., et al.
Publicado: (2013)

Considerations for and Mechanisms of Adjunct Therapy in COPD
por: Mandru, Rachana, et al.
Publicado: (2021)

Physicians' attitudes towards psycho‐oncology, perceived barriers, and psychosocial competencies: Indicators of successful implementation of adjunctive psycho‐oncological care?
por: Senf, Bianca, et al.
Publicado: (2018)

Stool donor screening within a Therapeutic Goods Administration compliant donor screening program for fecal microbiota transplantation
por: Tucker, Emily C, et al.
Publicado: (2023)

Bacteriophages as Fecal Pollution Indicators
por: Toribio-Avedillo, Daniel, et al.
Publicado: (2021)

Fecal Microbiota Transplantation (FMT) for Recurrent/Refractory Clostridium difficile Infection (CDI) in Pediatric Immunocompromised Patients: A Single-center Experience
por: Kwendakwema, Natasha, et al.
Publicado: (2017)

The Role of Microbiota and Immunobiotics in Granulopoiesis of Immunocompromised Hosts
por: Salva, Susana, et al.
Publicado: (2017)

Fecal microbiota transplantation augmented by a sulfide‐reducing diet for refractory ulcerative colitis: A case report with functional metagenomic analysis
por: Bryant, Robert V, et al.
Publicado: (2021)

HMPV in Immunocompromised Patients: Frequency and Severity in Pediatric Oncology Patients
por: Martinez-Rodriguez, Cesar, et al.
Publicado: (2020)

Fecal Microbiota Transplantation in Neurological Disorders
por: Vendrik, Karuna E. W., et al.
Publicado: (2020)

Weight Gain After Fecal Microbiota Transplantation
por: Alang, Neha, et al.
Publicado: (2015)

A Gut Instinct on Leukaemia: A New Mechanistic Hypothesis for Microbiota-Immune Crosstalk in Disease Progression and Relapse
por: Pagani, Ilaria S., et al.
Publicado: (2022)

Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations
por: Sinha, Rashmi, et al.
Publicado: (2016)

Fecal identification markers impact the feline fecal microbiota
por: Nealon, Nora Jean, et al.
Publicado: (2023)

Could Fecal Microbiota Be a Useful Indicator of Serum Cholesterol Levels among Men?
por: Chih, HuiJun, et al.
Publicado: (2020)

Cardio-Oncology Considerations in Oncologic Treatment Decisions
por: Fadol, Anecita P.
Publicado: (2022)

Antibacterial honey (Medihoney(®)) for wound care of immunocompromised pediatric oncology patients
por: Simon, Arne, et al.
Publicado: (2006)

Physician and patient perceptions of fecal microbiota transplant for recurrent or refractory Clostridioides difficile in the first 6 years of a central stool bank
por: Gill, Madeleine, et al.
Publicado: (2020)

Targeting the Gut–Brain Axis with Fecal Microbiota Transplantation: Considerations on a Potential Novel Treatment for Parkinson's Disease
por: Contarino, Maria Fiorella, et al.
Publicado: (2022)

Fecal microbiota in horses with asthma
por: Leclere, Mathilde, et al.
Publicado: (2020)

Fecal Microbiota Transplantation: Is It Safe?
por: Park, Seon-Young, et al.
Publicado: (2021)

Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients
por: Hérivaux, Anaïs, et al.
Publicado: (2022)

Impact of extent of parietal peritonectomy on oncological outcome after cytoreductive surgery and HIPEC
por: Somashekhar, S.P., et al.
Publicado: (2019)

Laboratory Aspects of Donor Screening for Fecal Microbiota Transplantation at a Korean Fecal Microbiota Bank
por: Seo, Hyun Soo, et al.
Publicado: (2021)

Laboratory Aspects of Donor Screening for Fecal Microbiota Transplantation at a Korean Fecal Microbiota Bank
por: Seo, Hyun Soo, et al.
Publicado: (2021)

Considerations for the development of a field-based medical device for the administration of adjunctive therapies for snakebite envenoming
por: Werner, R. Marshall, et al.
Publicado: (2023)

Characterization of rumen, fecal, and milk microbiota in lactating dairy cows
por: Williamson, Jenna R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hhbfaehdcdolku2d0irctamu8l